A new drug for heart failure could save lives

A drug developed in France has been used to treat patients with heart failure for a third year.

The French manufacturer of the drug says the treatment is safe and effective, and can prevent or even reverse some of the more serious side effects of heart failure.

The drug, called ezetimibe, is a synthetic version of the molecule called clomiphene citrate.

It is similar to a type of statin drugs used to lower cholesterol levels.

The FDA approved the drug in the United States in 2016 and the first trials have begun in Europe.

In France, it was initially approved in 2014 for people with heart disease but was eventually approved in 2020 to treat a broad range of heart conditions, including diabetes, obstructive sleep apnea and stroke.

The company says that this is the first drug approved for heart disease in Europe, with a goal to market it widely.

The heart failure drug is not a replacement for conventional therapies, and the FDA said it does not know when the drug might be available for patients.

The trial will be held in France from April to September.